Desq Long
Sign in

Company

Viridian Therapeutics, Inc.\DE

VRDN · CIK 0001590750

SEC FORM 4
$103,194.00

Viridian Therapeutics, Inc.\DE (VRDN)

Sale of 4,212 shares at $24.50 per share.

Reporting Person Tousignant Jennifer · Officer Title Chief Legal Officer · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001193125-26-359636 · filed 2026-08-20 · View filing →

SEC FORM 4
$144,100.00

Viridian Therapeutics, Inc.\DE (VRDN)

Acquisition (code M) of 10,000 shares at $14.41 per share.

Reporting Person Tousignant Jennifer · Officer Title Chief Legal Officer · Transaction Code M

Traded Aug 19, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001193125-26-359636 · filed 2026-08-20 · View filing →

SEC FORM 4
$245,000.00

Viridian Therapeutics, Inc.\DE (VRDN)

Sale of 10,000 shares at $24.50 per share.

Reporting Person Tousignant Jennifer · Officer Title Chief Legal Officer · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001193125-26-359636 · filed 2026-08-20 · View filing →

SEC FORM 4
$528,400.00

Viridian Therapeutics, Inc.\DE (VRDN)

Acquisition (code M) of 40,000 shares at $13.21 per share.

Reporting Person Tripuraneni Radhika · Officer Title Chief Medical Officer · Transaction Code M

Traded Aug 14, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001193125-26-355735 · filed 2026-08-18 · View filing →